<html><head><meta charset="UTF-8"><meta content="base mri brain ms followup contrast" name="dcterms.title"><meta content="85548eba-f3b1-4818-9afd-d9961a62fa5c" name="dcterms.identifier"><meta content="en" name="dcterms.language"><meta content="2019-01-31" name="dcterms.date"><meta content="Nuance System" name="dcterms.creator"><title>base mri brain ms followup contrast</title></head><body><section data-section-name="MRI BRAIN WITHOUT AND WITH CONTRAST, MS PROTOCOL"><header class="Level1">MRI BRAIN WITHOUT AND WITH CONTRAST, MS PROTOCOL</header><p><label>HISTORY:</label><input type="text" name="Patient Age" value="Patient Age"></p><p><label> old </label><input type="text" name="Patient Gender" value="Patient Gender"></p><p><label>, </label><input type="text" name="history" value="followup demyelinating disease."></p></section><section data-section-name="TECHNIQUE:"><header class="Level1">TECHNIQUE:</header><p><label>MR images of the brain were acquired without and with </label><input type="number" name="contrast dose"><label>mL Gadavist intravenous contrast.</label></p><p><label>COMPARISON: </label><input type="text" name="Comparison" value="None available."></p></section><section data-section-name="FINDINGS:"><header class="Level1">FINDINGS:</header><p><label>BRAIN PARENCHYMA</label><br><label>New T2 hyperintense Lesions: </label><input type="text" name="[new lesion number and location" value="None."></p><p><label>Enhancing Lesions: </label><input type="text" name="# of enhancing lesions and locations" value="None."></p><p><label>Reduced Diffusion: </label><input type="text" name="diffusion" value="None."></p><p><label>Overall Disease Burden: </label><select name="burden"><option name="" value=""><10 lesions.</option><option name="" value="">10-20 lesions.</option><option name="" value="">>20 lesions.</option></select></p><p><label> No change in multiple </label><select name="Plaque location"><option name="" value="" selected="">periventricular</option><option name="" value="" selected="">periventricular and juxtacortical</option><option name="" value="" selected="">periventricular, juxtacortical, and infratentorial</option></select><label>white matter lesions compatible with known demyelinating disease.</label></p><p><label>T1 Hypointensities (Black Holes): </label><select name="black holes"><option name="" value="">None.</option><option name="<5" value="<5"><5.</option><option name=">5" value=">5">>5.</option></select></p><p><label>Parenchymal Atrophy: </label><select name="parenchymal atrophy"><option name="" value="">None.</option><option name="" value="">Mild.</option><option name="" value="">Moderate.</option><option name="" value="">Severe.</option></select></p><p><label>Callosal Atrophy: </label><select name="callosal atrophy"><option name="" value="">None.</option><option name="" value="">Mild.</option><option name="" value="">Moderate.</option><option name="" value="">Severe.</option></select></p><p><label>OTHER: </label><input type="text" name="other" value="None."></p></section><section data-section-name="IMPRESSION:"><header class="Level1">IMPRESSION:</header><p><label>Demyelinating disease in the </label><select name="Location"><option name="" value="" selected="">supratentorial</option><option name="" value="" selected="">supratentorial and infratentorial</option></select></p><p><label> brain, </label><select name="active disease"><option name="" value="">without</option><option name="" value="">with</option></select></p><p><label> active disease and </label><select name="change"><option name="" value="">no change</option><option name="" value="">change</option></select></p><p><label> compared to </label><input type="text" name="Prior Exam"></p><p /></section></body></html>